Fate therapeutics to present at upcoming investor conferences

San diego, sept. 02, 2021 (globe newswire) -- fate therapeutics, inc. (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today announced that the company will present at the following upcoming investor conferences:

FATE Ratings Summary

FATE Quant Ranking